Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
Main Authors: | Fischer, Lara, Gerstel, Patricia Francis, Poncet, Antoine, Siegrist, Claire-Anne, Laffitte, Emmanuel, Gabay, Cem, Seebach, Joerg Dieter, Ribi, Camillo |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481118/ |
Similar Items
-
Galactosaminogalactan, a New Immunosuppressive Polysaccharide of Aspergillus fumigatus
by: Fontaine, Thierry, et al.
Published: (2011) -
STUDIES ON THE INDUCTION OF IMMUNOLOGICAL UNRESPONSIVENESS TO PNEUMOCOCCAL POLYSACCHARIDE IN MICE
by: Siskind, Gregory W., et al.
Published: (1966) -
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
by: MacLeod, Colin M., et al.
Published: (1945) -
Polysaccharide Responsiveness Is Not Biased by Prior Pneumococcal-Conjugate Vaccination
by: Bernth-Jensen, Jens Magnus, et al.
Published: (2013) -
Pneumococcal vaccination of older adults: Conjugate or polysaccharide?
by: Hollingsworth, Rosalind, et al.
Published: (2014)